← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M

$ Value

Shares

4,000

Price

Filed

Jun 23

Insider

Name

Mathers Edward T

Title

CIK

0001328625

Roles

Director

Transaction Details

Transaction Date

2025-06-18

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,000

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The Reporting Person is the trustee of the Edward Timothy Mathers Revocable Trust (the "Mathers Trust"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest. | The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date.

Filing Info

Accession No.

0000950170-25-089052

Form Type

4

Issuer CIK

0001649904

Mathers Edward T's History

Date Ticker Type Value
2025-12-31 OKUR A $0
2025-10-02 NEUE X $2K
2025-10-02 NEUE $2K
2025-10-02 NEUE M $2K
2025-10-02 NEUE F $2K
2025-10-02 NEUE D
2025-10-02 NEUE X $17K
2025-10-02 NEUE $17K
2025-10-02 NEUE X $6K
2025-10-02 NEUE $6K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01